Developer docs
API playgroundTry for free, no card

Search company profiles

Triumph Research Intelligence

Full company profile

uuid0008qcc

Namestring
Triumph Research Intelligence
Legal namestring
Triumph Research Intelligence Limited
Websiteurl
tritrials.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Triumph Research Intelligence (TRI) is a Cambridge, UK-based, privately held software company that builds and sells the OPRA platform — a cloud-based Risk-Based Quality Management (RBQM) suite for clinical trials — to pharmaceutical sponsors and contract research organizations. Founded in 2013 by CEO Duncan Hall, TRI has grown the platform across three interlocking modules: OPRA-CM (Centralized Monitoring, launched 2016 and substantially overhauled in 2025), OPRA-RAM (Risk Assessment & Management, launched 2020), and OPRA-SM (Subject Monitoring, launched 2026 for early-phase and low-volume trials). Collectively these modules automate monitoring workflows, surface risk signals via tailored statistical models, and produce audit-ready documentation aligned to 21 CFR Part 11 and ICH E6(R3). TRI reports 450+ clinical trials running on OPRA globally and claims up to 30% reductions in monitoring costs and trial-efficiency gains; approximately 30% of work is concentrated in oncology studies. Named customers include Worldwide Clinical Trials (running 150 trials on the platform), Roche, IQVIA, Alimentiv, Caidya, Emmes, Klifo, Catalyst, and Advanced Clinical — a mix of top-tier CROs and a major pharma sponsor.

TRI generates revenue primarily through enterprise SaaS subscriptions for the OPRA platform, with additional contribution from implementation, configuration, and training professional services, plus CPD-certified e-Learning licensing (GCP, ICH E8(R1), and Risk Assessment courses). The company sells exclusively via direct enterprise field sales, with 'Book a Demo' CTAs, a savings calculator tool, and consultative quote-based pricing rather than transparent tiers. Distribution is direct-only with no disclosed channel partners, resellers, or marketplace listings; the company operates a remote-first model from its Cambridge headquarters (1 Signet Court, Swanns Road, CB5 8LA), with a US operating subsidiary (Triumph Consultancy Services, Inc) supporting North American commercial activity.

TRI's go-to-market targets pharmaceutical sponsors and CROs through industry events (SCOPE, SCDM, OCT, CRO Summit), webinars, content marketing (RBQM guides, whitepapers, monthly 'The Quality Issue' newsletter), and an active LinkedIn presence. The leadership bench was recently strengthened by the appointment of Jamie Moss — formerly Group COO and CEO of Enterprise Technologies at Calyx (Parexel Informatics) and global operations lead at CRF Health — as Executive Chair, signaling institutional scaling intent. Other executives include COO Tammy Finnigan, Chief Strategy Officer Dale Jessop (two prior eClinical trade sales and one IPO), CTPO Becky Read, CCO Caroline O'Connor, SVP of Sales Tim Collard, and dedicated Heads of Marketing and HR.

Short descriptiontext

Triumph Research Intelligence is a Cambridge, UK-based SaaS provider of the OPRA Risk-Based Quality Management platform for clinical trials, serving pharmaceutical sponsors and CROs with centralized monitoring, risk assessment, and subject monitoring modules across 450+ trials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCambridge, United Kingdom
HQ citystring
Cambridge
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
risk-based quality management, clinical trial monitoring, centralized monitoring software, clinical risk assessment, pharmaceutical RBQM platform
Industry3 codes
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Risk-Based Monitoring Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1OPRA Platform Subscription
TypeSubscription Recurring
Description

SaaS subscription model providing access to the OPRA platform modules (CM, RAM, SM) for centralized monitoring, risk assessment, and subject monitoring. Revenue generated through recurring subscription fees based on usage scope, study count, or enterprise-wide deployment.

tritrials.com
2e-Learning Services
TypeSubscription Recurring
Description

CPD-certified e-learning courses for GCP training, ICH E8(R1), and Risk Assessment and Controls. Delivered as standalone courses or integrated into LMS systems, generating revenue through course licensing or per-user access fees.

tritrials.com
3Professional Services
TypeProfessional Services
Description

Implementation services including onboarding support, custom configuration, training for system admins and super users, and ongoing customer support. Assigned full implementation team to each client with templates, sandbox testing, and walkthroughs.

tritrials.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1OPRA-CM
Description

Centralized monitoring platform for clinical trials that delivers dynamic, structured views surfacing evolving risk signals and providing actionable insights.

tritrials.com
+2 more records
Core offering1 text field

TRI provides the OPRA platform, a cloud-based Risk-Based Quality Management (RBQM) software suite for clinical trials, comprising OPRA-CM (Centralized Monitoring), OPRA-RAM (Risk Assessment and Management), and OPRA-SM (Subject Monitoring) modules. The platform helps pharmaceutical sponsors and Contract Research Organizations (CROs) reduce monitoring costs, achieve compliance with ICH E6(R3) and 21 CFR Part 11, and proactively manage risks across all trial phases. TRI also offers CPD-certified e-learning courses covering GCP, ICH E8(R1), and Risk Assessment and Controls.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduce monitoring costs by up to 30%
+3 more records
Product overview1 text field

Triumph Research Intelligence (TRI) offers OPRA, a unified RBQM platform consisting of three interconnected modules: OPRA-CM (Centralized Monitoring) for trial oversight and risk signal detection, OPRA-RAM (Risk Assessment & Management) for proactive risk identification and mitigation, and OPRA-SM (Subject Monitoring) for subject-level oversight in early-phase studies. The platform is designed to reduce monitoring costs by up to 30% while improving trial quality and patient safety. TRI also provides complementary e-learning training modules (CPD-certified GCP, ICH E8, Risk Assessment courses) and a Savings Calculator tool. The platform is 21 CFR Part 11 compliant and supports all trial phases, with specific expertise in oncology trials (approximately 30% of work).

Product and service5 records
1OPRA Central Monitoring (OPRA-CM)
CategoryRBQM Software Module
Description

Centralized monitoring module that connects clinical and operational data in a single intuitive environment, providing dynamic risk signal surfacing, automated workflows, real-time insights, and KRIs/QTLs oversight for pharmaceutical sponsors and CROs.

2OPRA Risk Assessment & Management (OPRA-RAM)
CategoryRBQM Software Module
Description

Risk assessment and management module that empowers clinical researchers to proactively identify, evaluate, and mitigate risks; includes standardized risk libraries, visual risk dashboards, central activity management, and one-click PDF reports.

3OPRA Subject Monitoring (OPRA-SM)
CategoryRBQM Software Module
Description

Subject-level monitoring solution designed for early-phase and low-volume clinical trials that displays all visits, adverse events, labs, dosing, and assessments on a single chronological timeline with built-in audit trail and role-based access control.

4OPRA Platform
CategoryRBQM Platform
Description

Comprehensive cloud-based RBQM platform encompassing OPRA-CM, OPRA-RAM, and OPRA-SM modules to deliver centralized risk management, monitoring oversight, and subject-level insight across all clinical trial phases for sponsors and CROs.

5TRI e-Learning
CategoryTraining and Certification
Description

CPD-certified e-learning platform for clinical trial training covering Good Clinical Practice (GCP), ICH E8(R1), and Risk Assessment and Controls, featuring scenario-based interactive content delivered via role-specific learning pathways for clinical research professionals.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1ACRO
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TRI collaborates with ACRO (Association of Clinical Research Organizations) as an active participant in industry working groups. TRI references ACRO's RBQM reports and guidelines, and contributes to industry discussions on RBQM adoption and regulatory alignment.

tritrials.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Veeva's Vault CTMS and broader clinical suite compete with TRI for enterprise pharma and CRO spend, with RBQM increasingly folded into its broader platform roadmap.

TypeDirect peer
Description

CluePoints is the most directly comparable specialist RBQM and centralized statistical monitoring platform for clinical trials, competing head-to-head with TRI's OPRA-CM and OPRA-RAM modules across the same sponsor and CRO buyer base.

TypeDirect peer
Description

Signant Health offers an eClinical suite that includes RBQM, eCOA, and patient-centric clinical technology, directly overlapping TRI's RBQM positioning while serving the same pharmaceutical sponsor and CRO customers.

TypeDirect peer
Description

eClinical Solutions offers the elluminate clinical data platform with RBM/RBQM capabilities, serving biopharma sponsors and CROs with overlapping centralized monitoring and risk-based quality management functionality.

TypeBroad incumbent
Description

Medidata's Rave platform includes RBQM-adjacent capabilities within one of the industry's broadest clinical trial technology suites, competing with TRI at the enterprise procurement level even though RBQM is not its core focus.

6Oracle Health Sciences
TypeBroad incumbent
Description

Oracle Clinical One offers unified clinical trial operations including risk-based monitoring, competing as a large-scale enterprise incumbent that can absorb RBQM functionality into broader deals.

TypeEmerging player
Description

Cytel delivers statistical and clinical analytics services including risk-based monitoring enablement for biopharma, overlapping with TRI in the centralized monitoring and statistical risk analytics layer.

TypeEmerging player
Description

Saama provides AI-driven clinical analytics and operational data platforms that intersect with TRI's RBQM use cases, particularly around risk signal detection and trial oversight.

TypeOthers
Description

Worldwide Clinical Trials is both a TRI customer and a CRO that offers its own centralized monitoring and RBQM services, representing the buyer side of TRI's market as well as a potential competitor in services.

10WCG
TypeOthers
Description

WCG provides clinical trial services and technology with risk-based monitoring capabilities that intersect with TRI's platform, serving many of the same sponsors and CROs as a broader clinical services partner.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Triumph Research Intelligence

Clinical Trial Risk-Based Monitoring Softwaretritrials.com

Triumph Research Intelligence is a Cambridge, UK-based SaaS provider of the OPRA Risk-Based Quality Management platform for clinical trials, serving pharmaceutical sponsors and CROs with centralized monitoring, risk assessment, and subject monitoring modules across 450+ trials.

What Triumph Research Intelligence does

Triumph Research Intelligence (TRI) is a Cambridge, UK-based, privately held software company that builds and sells the OPRA platform — a cloud-based Risk-Based Quality Management (RBQM) suite for clinical trials — to pharmaceutical sponsors and contract research organizations. Founded in 2013 by CEO Duncan Hall, TRI has grown the platform across three interlocking modules: OPRA-CM (Centralized Monitoring, launched 2016 and substantially overhauled in 2025), OPRA-RAM (Risk Assessment & Management, launched 2020), and OPRA-SM (Subject Monitoring, launched 2026 for early-phase and low-volume trials). Collectively these modules automate monitoring workflows, surface risk signals via tailored statistical models, and produce audit-ready documentation aligned to 21 CFR Part 11 and ICH E6(R3). TRI reports 450+ clinical trials running on OPRA globally and claims up to 30% reductions in monitoring costs and trial-efficiency gains; approximately 30% of work is concentrated in oncology studies. Named customers include Worldwide Clinical Trials (running 150 trials on the platform), Roche, IQVIA, Alimentiv, Caidya, Emmes, Klifo, Catalyst, and Advanced Clinical — a mix of top-tier CROs and a major pharma sponsor.

TRI generates revenue primarily through enterprise SaaS subscriptions for the OPRA platform, with additional contribution from implementation, configuration, and training professional services, plus CPD-certified e-Learning licensing (GCP, ICH E8(R1), and Risk Assessment courses). The company sells exclusively via direct enterprise field sales, with 'Book a Demo' CTAs, a savings calculator tool, and consultative quote-based pricing rather than transparent tiers. Distribution is direct-only with no disclosed channel partners, resellers, or marketplace listings; the company operates a remote-first model from its Cambridge headquarters (1 Signet Court, Swanns Road, CB5 8LA), with a US operating subsidiary (Triumph Consultancy Services, Inc) supporting North American commercial activity.

TRI's go-to-market targets pharmaceutical sponsors and CROs through industry events (SCOPE, SCDM, OCT, CRO Summit), webinars, content marketing (RBQM guides, whitepapers, monthly 'The Quality Issue' newsletter), and an active LinkedIn presence. The leadership bench was recently strengthened by the appointment of Jamie Moss — formerly Group COO and CEO of Enterprise Technologies at Calyx (Parexel Informatics) and global operations lead at CRF Health — as Executive Chair, signaling institutional scaling intent. Other executives include COO Tammy Finnigan, Chief Strategy Officer Dale Jessop (two prior eClinical trade sales and one IPO), CTPO Becky Read, CCO Caroline O'Connor, SVP of Sales Tim Collard, and dedicated Heads of Marketing and HR.

Triumph Research Intelligence firmographics

Firmographics
Name
Triumph Research Intelligence
Legal name
Triumph Research Intelligence Limited
Website
https://tritrials.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
101–250 employees
Short description
Triumph Research Intelligence is a Cambridge, UK-based SaaS provider of the OPRA Risk-Based Quality Management platform for clinical trials, serving pharmaceutical sponsors and CROs with centralized monitoring, risk assessment, and subject monitoring modules across 450+ trials.
Ownership category
akta.pro rank

Triumph Research Intelligence industry classification

Industry
Product category
Clinical Trial Risk-Based Monitoring Software
NAICS
Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGACAF
Investigator & Site Training / GCP Support

Keywords

  • Risk-based quality management
  • Clinical trial monitoring
  • Centralized monitoring software
  • Clinical risk assessment
  • Pharmaceutical RBQM platform

Where Triumph Research Intelligence is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Triumph Research Intelligence business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. OPRA Platform Subscription: SaaS subscription model providing access to the OPRA platform modules (CM, RAM, SM) for centralized monitoring, risk assessment, and subject monitoring. Revenue generated through recurring subscription fees based on usage scope, study count, or enterprise-wide deployment.
  2. e-Learning Services: CPD-certified e-learning courses for GCP training, ICH E8(R1), and Risk Assessment and Controls. Delivered as standalone courses or integrated into LMS systems, generating revenue through course licensing or per-user access fees.
  3. Professional Services: Implementation services including onboarding support, custom configuration, training for system admins and super users, and ongoing customer support. Assigned full implementation team to each client with templates, sandbox testing, and walkthroughs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Triumph Research Intelligence product offering

Product offering

Core offering

TRI provides the OPRA platform, a cloud-based Risk-Based Quality Management (RBQM) software suite for clinical trials, comprising OPRA-CM (Centralized Monitoring), OPRA-RAM (Risk Assessment and Management), and OPRA-SM (Subject Monitoring) modules. The platform helps pharmaceutical sponsors and Contract Research Organizations (CROs) reduce monitoring costs, achieve compliance with ICH E6(R3) and 21 CFR Part 11, and proactively manage risks across all trial phases. TRI also offers CPD-certified e-learning courses covering GCP, ICH E8(R1), and Risk Assessment and Controls.

Product overview

Triumph Research Intelligence (TRI) offers OPRA, a unified RBQM platform consisting of three interconnected modules: OPRA-CM (Centralized Monitoring) for trial oversight and risk signal detection, OPRA-RAM (Risk Assessment & Management) for proactive risk identification and mitigation, and OPRA-SM (Subject Monitoring) for subject-level oversight in early-phase studies. The platform is designed to reduce monitoring costs by up to 30% while improving trial quality and patient safety. TRI also provides complementary e-learning training modules (CPD-certified GCP, ICH E8, Risk Assessment courses) and a Savings Calculator tool. The platform is 21 CFR Part 11 compliant and supports all trial phases, with specific expertise in oncology trials (approximately 30% of work).

Differentiator

Problem solved

Functional benefit

Brands

  • OPRA-CM: Centralized monitoring platform for clinical trials that delivers dynamic, structured views surfacing evolving risk signals and providing actionable insights.
  • OPRA-RAM
  • OPRA-SM

Products and services

  • OPRA Central Monitoring (OPRA-CM) Centralized monitoring module that connects clinical and operational data in a single intuitive environment, providing dynamic risk signal surfacing, automated workflows, real-time insights, and KRIs/QTLs oversight for pharmaceutical sponsors and CROs.
  • OPRA Risk Assessment & Management (OPRA-RAM) Risk assessment and management module that empowers clinical researchers to proactively identify, evaluate, and mitigate risks; includes standardized risk libraries, visual risk dashboards, central activity management, and one-click PDF reports.
  • OPRA Subject Monitoring (OPRA-SM) Subject-level monitoring solution designed for early-phase and low-volume clinical trials that displays all visits, adverse events, labs, dosing, and assessments on a single chronological timeline with built-in audit trail and role-based access control.
  • OPRA Platform Comprehensive cloud-based RBQM platform encompassing OPRA-CM, OPRA-RAM, and OPRA-SM modules to deliver centralized risk management, monitoring oversight, and subject-level insight across all clinical trial phases for sponsors and CROs.
  • TRI e-Learning CPD-certified e-learning platform for clinical trial training covering Good Clinical Practice (GCP), ICH E8(R1), and Risk Assessment and Controls, featuring scenario-based interactive content delivered via role-specific learning pathways for clinical research professionals.

Quantifiable outcome

  • Reduce monitoring costs by up to 30%
  • +3 more outcomes

Companies that use Triumph Research Intelligence

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles2 records

Triumph Research Intelligence technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Triumph Research Intelligence partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ACROcoreStrategic or Co-development PartnerTRI collaborates with ACRO (Association of Clinical Research Organizations) as an active participant in industry working groups. TRI references ACRO's RBQM reports and guidelines, and contributes to industry discussions on RBQM adoption and regulatory alignment.

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Triumph Research Intelligence competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva's Vault CTMS and broader clinical suite compete with TRI for enterprise pharma and CRO spend, with RBQM increasingly folded into its broader platform roadmap.
  • Medidata Solutions (Dassault Systèmes): Medidata's Rave platform includes RBQM-adjacent capabilities within one of the industry's broadest clinical trial technology suites, competing with TRI at the enterprise procurement level even though RBQM is not its core focus.
  • Oracle Health Sciences: Oracle Clinical One offers unified clinical trial operations including risk-based monitoring, competing as a large-scale enterprise incumbent that can absorb RBQM functionality into broader deals.

Direct peers

  • CluePoints: CluePoints is the most directly comparable specialist RBQM and centralized statistical monitoring platform for clinical trials, competing head-to-head with TRI's OPRA-CM and OPRA-RAM modules across the same sponsor and CRO buyer base.
  • Signant Health: Signant Health offers an eClinical suite that includes RBQM, eCOA, and patient-centric clinical technology, directly overlapping TRI's RBQM positioning while serving the same pharmaceutical sponsor and CRO customers.
  • eClinical Solutions: eClinical Solutions offers the elluminate clinical data platform with RBM/RBQM capabilities, serving biopharma sponsors and CROs with overlapping centralized monitoring and risk-based quality management functionality.

Emerging players

  • Cytel: Cytel delivers statistical and clinical analytics services including risk-based monitoring enablement for biopharma, overlapping with TRI in the centralized monitoring and statistical risk analytics layer.
  • Saama Technologies: Saama provides AI-driven clinical analytics and operational data platforms that intersect with TRI's RBQM use cases, particularly around risk signal detection and trial oversight.

Others

  • Worldwide Clinical Trials: Worldwide Clinical Trials is both a TRI customer and a CRO that offers its own centralized monitoring and RBQM services, representing the buyer side of TRI's market as well as a potential competitor in services.
  • WCG: WCG provides clinical trial services and technology with risk-based monitoring capabilities that intersect with TRI's platform, serving many of the same sponsors and CROs as a broader clinical services partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Triumph Research Intelligence social profiles

Digital presence

Triumph Research Intelligence compliance and trust

Trust signal

Compliance3 records

Triumph Research Intelligence financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Triumph Research Intelligence leadership team

Management profile

Number of profiles

Profiles9 records

Triumph Research Intelligence subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Triumph Research Intelligence funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Triumph Research Intelligence M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Triumph Research Intelligence

What does Triumph Research Intelligence do?

TRI provides the OPRA platform, a cloud-based Risk-Based Quality Management (RBQM) software suite for clinical trials, comprising OPRA-CM (Centralized Monitoring), OPRA-RAM (Risk Assessment and Management), and OPRA-SM (Subject Monitoring) modules. The platform helps pharmaceutical sponsors and Contract Research Organizations (CROs) reduce monitoring costs, achieve compliance with ICH E6(R3) and 21 CFR Part 11, and proactively manage risks across all trial phases. TRI also offers CPD-certified e-learning courses covering GCP, ICH E8(R1), and Risk Assessment and Controls.

Is Triumph Research Intelligence a public or private company?

Triumph Research Intelligence is a private company. It is classified as venture growth investor backed and is currently operating.

When was Triumph Research Intelligence founded?

Triumph Research Intelligence was founded in 2013. It employs 101 to 250 people.

Where is Triumph Research Intelligence based?

Triumph Research Intelligence is headquartered in Cambridge, United Kingdom, in the Europe region.

How does Triumph Research Intelligence make money?

Three revenue lines are on record. OPRA Platform Subscription is the primary driver. The others are e-Learning Services and professional Services.

Who are Triumph Research Intelligence's main competitors?

Broad incumbents on record are Veeva Systems, Medidata Solutions (Dassault Systèmes) and Oracle Health Sciences. Direct peers are CluePoints, Signant Health and eClinical Solutions. Emerging players are Cytel and Saama Technologies. Others are Worldwide Clinical Trials and WCG.

Does Triumph Research Intelligence have an API?

No public API is recorded for Triumph Research Intelligence.

What industry is Triumph Research Intelligence in?

Triumph Research Intelligence's product category is Clinical Trial Risk-Based Monitoring Software. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals